ArticleScientific reports2025
Sarcopenia is associated with increased hip fracture risk among middle-aged and elderly Chinese adults in longitudinal analysis of CHARLS data.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Water Distribution in the Body as a Source of Information on Markers of Skeletal Muscle Ageing.Nutrients · 2026Article
- [Analysis of disease burden of fall-related fractures among elderly Chinese from 1990 to 2023].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2026Article
- Sarcopenia and fall-related outcomes in Chinese adults aged 45 years or older: a longitudinal cohort study.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
To investigate the temporal association between sarcopenia and hip fracture risk among middle-aged and elderly Chinese adults, given the rising prevalence of sarcopenia and increasing burden of hip fractures in aging populations. This longitudinal study analyzed data from 7775 participants aged ≥ 45 years in the China Health and Retirement Longitudinal Study (2011-2020). Sarcopenia was assessed based on muscle strength, mass, and physical performance. Hip fracture incidents were collected through follow-up interviews. Covariates included demographic characteristics, lifestyle factors (smoking, alcohol consumption), and chronic diseases (hypertension, diabetes, arthritis). Competing risk analysis and multiple logistic regression models were employed to evaluate the association between sarcopenia and hip fracture risk. At baseline, 1436 (18.5%) participants had sarcopenia. The sarcopenia group showed higher hip fracture incidence than the non-sarcopenia group ((7.17% vs. 3.75%, P < 0.001). Cumulative incidence analysis revealed progressively widening disparity in fracture incidence between groups over the 9-year follow-up. After adjusting for multiple confounders, sarcopenia remained independently associated with increased hip fracture risk (adjusted OR = 1.33, 95% CI: 1.00-1.77, P = 0.0498). Sarcopenia serves as an independent risk factor for hip fracture among middle-aged and elderly Chinese adults, emphasizing the importance of early sarcopenia identification and prevention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.